EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Enhanced Exome Sequencing Improves the Genetic Diagnosis of Deafblindness

Guadalupe A Cifuentes, Marta Diñeiro, Alicia R Huete, Raquel Capín iD, Adrián Santiago iD, Alberto A R Vargas, Dido Carrero, Julien Biscay, Esther López Martínez, Beatriz Aguiar, María Urbaniak, Beatriz Fernández-Vega und 4 weitere

Genes · 19.03.2026 · 17 (3) · 344

DOI: 10.3390/genes17030344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 19.03.2026. Verfasst von Guadalupe A Cifuentes und 15 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Centro Médico de Asturias, 33193 Oviedo, Spain. Hauptthemen laut MEDLINE: Exome Sequencing, Exome, Deaf-Blind Disorders, Genetic Testing. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación María Cristina Masavey Peterson, Organización Nacional de Ciegos Españoles.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The combination of hearing loss and visual impairment in a single patient strongly suggests a genetic aetiology. However, after conventional testing, a considerable proportion of deafblindness cases remain without a genetic diagnosis. The aim of this study was to address this diagnostic gap.

Methods

We developed an enhanced exome strategy that uses a whole-exome backbone complemented by spike-in capture probes for (i) low-coverage coding segments and clinically validated, non-coding regions (including deep intronic splice-altering sites and untranslated exonic sequences) across 659 genes associated with hearing loss and/or visual impairment, and (ii) mitochondrial DNA.

Results

With 66.6 million paired-end reads per sample, this methodology achieved coverage of at least 20 reads per base at 99.3% of target coding and non-coding positions of genes associated with deafness and/or blindness, as well as 98.8% of the whole exome. The enhanced exome approach correctly identified the genetic variants causative of deafness and/or blindness in 10 out of 10 cases with a previously known genetic cause, in 3 out of 10 additional cases that remained undiagnosed after extensive panel sequencing, and in 4 out of 4 cases that had not been genetically studied before. Comparison of the performance of two commercial bioinformatics platforms for enhanced exome interpretation revealed that eVAI consistently prioritised causative variants higher than, or as high as, VarSome Clinical, resulting in a tendency toward shorter interpretation times using the former. Both platforms offered the same diagnostic yield and both failed to correctly call one of the causative variants.

Conclusions

In an era where many centres operate exome analysis through virtual panels, enhanced exome sequencing leverages the advantages of whole-exome and custom panel sequencing: it provides panel-like sensitivity for clinically actionable loci, while offering the flexibility to periodically reanalyse data and discover candidate genes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Exome SequencingExomeDeaf-Blind DisordersGenetic TestingHumansDeafness

Stichwörter der Autor:innen

candidate gene discoverydeafblindnessgenetic diagnosisnon-coding variantspanel sequencingvirtual gene panelswhole-exome sequencing

Autor:innen und Institutionen

  • Fundación Centro Médico de Asturias, 33193 Oviedo, Spain.
  • Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.
  • Hospital Centro Médico de Asturias, 33193 Oviedo, Spain.
  • Instituto Oftalmológico Fernández-Vega, 33012 Oviedo, Spain.
  • Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
  • Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.

ORCID-Profile: Raquel Capín, Adrián Santiago, Rocío González-Aguado, Juan Cadiñanos

Förderung

  • Fundación María Cristina Masavey Peterson
  • Organización Nacional de Ciegos Españoles

Zitieren

APA

Cifuentes, G. A., Diñeiro, M., Huete, A. R., Capín, R., Santiago, A., Vargas, A. A. R., Carrero, D., Biscay, J., López Martínez, E., Aguiar, B., Urbaniak, M., Fernández-Vega, B., Costales, M., González-Aguado, R., Cabanillas, R., & Cadiñanos, J. (2026). Enhanced Exome Sequencing Improves the Genetic Diagnosis of Deafblindness. Genes, 17(3), 344. https://doi.org/10.3390/genes17030344

Vancouver

Cifuentes GA, Diñeiro M, Huete AR, Capín R, Santiago A, Vargas AAR, et al. Enhanced Exome Sequencing Improves the Genetic Diagnosis of Deafblindness. Genes. 2026;17(3):344. doi:10.3390/genes17030344

BibTeX
@article{Cifuentes2026,
  author = {Cifuentes, Guadalupe A and Diñeiro, Marta and Huete, Alicia R and Capín, Raquel and Santiago, Adrián and Vargas, Alberto A R and Carrero, Dido and Biscay, Julien and López Martínez, Esther and Aguiar, Beatriz and Urbaniak, María and Fernández-Vega, Beatriz and Costales, María and González-Aguado, Rocío and Cabanillas, Rubén and Cadiñanos, Juan},
  title = {Enhanced Exome Sequencing Improves the Genetic Diagnosis of Deafblindness},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {344},
  doi = {10.3390/genes17030344}
}
Kostenlos starten →